• A Study of Zanidatamab for Patients with Previously Treated HER2-Expressing Solid Tumors

    Recruiting

    2 1 1
    Investigated drugs:
    Spain
  • A study to evaluate the long-term safety and effectiveness of afimkibart in patients with atopic dermatitis who took part in previous afimkibart studies

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Spain
  • A Study to Test How Safe Budoprutug Is and How Well It Works in Patients with Immune Thrombocytopenia

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Greece Spain
  • Study of herbal medicine combination and bromazepam for anxiety and pain in patients having eye surgery with retrobulbar anesthesia

    Recruiting

    3 1 1 1
    Investigated diseases:
    Austria
  • A study testing venetoclax for treating acute graft-versus-host disease in patients who received a stem cell transplant from a donor

    Recruiting

    2 1 1 1
    Investigated drugs:
    Austria
  • A study to test the safety and effectiveness of BAY 3713372 alone and with drug combination in patients with MTAP-deleted solid tumors

    Recruiting

    2 1 1 1
    Belgium Czechia Denmark Italy The Netherlands Spain +1
  • A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

    Recruiting

    3 1 1
    Investigated diseases:
    Austria Belgium Finland France Germany Hungary +5
  • Study of fianlimab plus cemiplimab with chemotherapy or cemiplimab with chemotherapy for patients with pleural mesothelioma who have not received prior treatment

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Vorasidenib for patients with IDH-mutant grade 2 or 3 astrocytoma after completing first-line chemoradiotherapy

    Recruiting

    3 1
    Investigated drugs:
    Austria Belgium Czechia France Germany Italy +2
  • Testing dehydroepiandrosterone combined with standard antidepressants for patients with treatment-resistant depression

    Recruiting

    3 1 1
    Investigated diseases:
    Germany

powered by